4//SEC Filing
Hrustanovic Gorjan 4
Accession 0000899243-21-024442
CIK 0001815442other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:48 PM ET
Size
5.9 KB
Accession
0000899243-21-024442
Insider Transaction Report
Form 4
Hrustanovic Gorjan
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+20,063→ 20,063 totalExercise: $49.10Exp: 2031-06-15→ Common Stock (20,063 underlying)
Footnotes (2)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.
- [F2]The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821194
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:48 PM ET
- Size
- 5.9 KB